(Total Views: 231)
Posted On: 12/11/2017 8:23:14 AM
Post# of 72440
Re: NotRichYet2 #39834
I'm really curious how the market is going to react to this one. I wouldn't even begin to wager a guess.
Pros:
-We have completed the trial successfully with solid top line results.
-Now there is nothing stopping a Brilacidin deal of some kind now.
-Secondary endpoint data could be much stronger than top line.
-The bar is low for OM treatment.
Cons:
-The post-interim results of the trial appear to be notably worse than those presented at interim.
Am I off base with my conclusions? If so, please correct me. Feeling quite mixed about the results.
Go IPIX!
Pros:
-We have completed the trial successfully with solid top line results.
-Now there is nothing stopping a Brilacidin deal of some kind now.
-Secondary endpoint data could be much stronger than top line.
-The bar is low for OM treatment.
Cons:
-The post-interim results of the trial appear to be notably worse than those presented at interim.
Am I off base with my conclusions? If so, please correct me. Feeling quite mixed about the results.
Go IPIX!
(0)
(0)
All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.
Scroll down for more posts ▼
